Ethical considerations in HIV prevention and vaccine research in resource-limited settings
Garner SA, Anude CJ, Adams E, Dawson L, J Acquir Immune Defic Syndr, 1/1/2014The immune space: a concept and template for rationalizing vaccine development
Manrique A, Adams E, Barouch DH, Fast P, Graham BS, Kim JH, Kublin JG, McCluskey M, Pantaleo G, Robinson HL, Russell N, Snow W, Johnston MI, AIDS Res Hum Retroviruses, 1/1/2014Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine
Hammer SM, Sobieszczyk ME, Janes H, Karuna ST, Mulligan MJ, Grove D, Koblin BA, Buchbinder SP, Keefer MC, Tomaras GD, Frahm N, Hural J, Anude C, Graham BS, Enama ME, A..., N Engl J Med, 1/1/2013Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX...
Rerks-Ngarm S, Paris RM, Chunsutthiwat S, Premsri N, Namwat C, Bowonwatanuwong C, Li SS, Kaewkungkal J, Trichavaroj R, Churikanont N, de Souza MS, Andrews C, Francis D..., J Infect Dis, 1/1/2013Risk behavior and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy tria...
Robb ML, Rerks-Ngarm S, Nitayaphan S, Pitisuttithum P, Kaewkungwal J, Kunasol P, Khamboonruang C, Thongcharoen P, Morgan P, Benenson M, Paris RM, Chiu J, Adams E, Fran..., Lancet Infect Dis, 1/1/2012A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine Regimens
Gilbert, PB et al, Stat Communications in Infectious Disease, 1/1/2011A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)
Churchyard GJ, Morgan C, Adams E, Hural J, Graham BS, Moodie Z, Grove D, Gray G, Bekker LG, McElrath MJ, Tomaras GD, Goepfert P, Kalams S, Baden LR, Lally M, Dolin R, ..., PLoS One, 1/1/2011Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa
Jaoko W, Karita E, Kayitenkore K, Omosa-Manyonyi G, Allen S, Than S, Adams EM, Graham BS, Koup RA, Bailer RT, Smith C, Dally L, Farah B, Anzala O, Muvunyi CM, Bizimana..., PLoS One, 1/1/2010A randomized therapeutic vaccine trial of canary pox-HIV-pulsed dendritic cells vs canary pox-HIV alone in HIV-1-infected patients on antiretroviral therapy
Gandhi RT, O'Neill D, Bosch RJ, Chan ES, Bucy RP, Shopis J, Baglyos L, Adams E, Fox L, Purdue L, Marshak A, Flynn T, Masih R, Schock B, Mildvan D, Schlesinger SJ, Maro..., Vaccine, 1/1/2009Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand
Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil J..., N Engl J Med, 1/1/2009Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks
Okusanya O, Forrest A, DiFrancesco R, Bilic S, Rosenkranz S, Para MF, Adams E, Yarasheski KE, Reichman RC, Morse GD and ACTG 5043 Protocol Team, Antimicrob Agents Chemother, 1/1/2007Amprenavir and efavirenz pharmacokinetics before and after the addition of nelfinavir, indinavir, ritonavir, or saquinavir in seronegative individuals
Morse GD, Rosenkranz S, Para MF, Segal Y, Difrancesco R, Adams E, Brizz B, Yarasheski KE, and Reichman RC, Antimicrob Agents Chemother, 1/1/2005Safety and immunogenicity of a polyvalent peptide C4-V3 HIV vaccine in conjunction with interleukin-12
Sha BE, Onorato M, Bartlett JA, Bosch RJ, Aga E, Nokta M, Casey G, Adams EM, Li X-D, Estep SG and Pollard RB, AIDS, 1/1/2004Defining Clinical Improvement in Adult and Juvenile Myositis
Rider LG, Giannini EH, Harris-Love M, Joe G, Isenberg D, Pilkington C, Lachenbruch PA, Miller FW; International Myositis Assessment and Clinical Studies Group, J Rheumatol, 1/1/2003Proposed Preliminary Core Set Measures for Disease Outcome Assessment in Adult and Juvenile Idiopathic Inflammatory Myopathies
Miller FW, Rider LG, Chung YL, Cooper R, Danko K, Farewell V, Lundberg I, Morrison C, Oakley L, Oakley I, Pilkington C, Vencovsky J, Vincent K, Scott DL, Isenberg DA, ..., Rheumatology (Oxford), 1/1/2001Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression
Havlir DV, Gilbert PB, Bennett K, Collier AC, Hirsch MS, Tebas P, Adams EM, Wheat LJ, Goodwin D, Schnittman S, Holohan MK, Richman DD, ACTG 5025 Study Group, AIDS, 1/1/2001Therapeutic Vaccines for Treatment of HIV Infection
Adams, EM and Fox, L, Clin and Appl Immunol Revs, 1/1/2000A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis and examination of endpoint measures
Adams, EM, Pucino, F, Yarboro, C, Hicks, JE, Thornton, B, McGarvey, C, Sonies, BC, Bartlett, ML, Villalba, ML, Fleisher, T, and Plotz, P, J Rheumatol, 1/1/1999Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens
Villalba, L, Hicks, JE, Adams, EM, Sherman, J, Gourley, M, Leff, R, Thornton, B, Burgess, S, Plotz, P, and Miller, F, Arthritis Rheum, 1/1/1998The African origin of the common mutation in African-American patients with Glycogen Storage Disease Type II (GSD II)
Becker, J, Vlach J, Raben, N, Nagaraju, K, Adams, EM, Hermans, MM, Reuser AJJ, Brooks, SS, Tift, CJ , Hirshorn, R, Huie, ML, Nicolino, M, and Plotz, PH, Am J Hum Genetics, 1/1/1998The predominance of beta (CC) chemokines in the muscle from patients with idiopathic inflammatory muscle diseases
Adams, EM, Kirkley, J, Eidelman, G, Dohlman, J, and Plotz, PH, Proc Assoc Am Phys, 1/1/1997Glycogenosis Type II: a juvenile specific mutation with an unusual splicing pattern and a shared mutation in African Americans
Adams, EM, Becker, JA, Griffith, L, Segal, A, Plotz, PH, and Raben, N, Hum Mut, 1/1/1997Retroviral Transfer of acid alpha?-glucosidase cDNA to enzyme-deficient myoblasts results in phenotypic spread of the genotypic correction by both secretion and fusion
Zaretsky, JZ, Condotti, F, Boerkoel, C, Adams, EM, Yewdell, JW, Blaese, RM, and Plotz, PH, Hum Gene Therapy, 1/1/1997Abnormal numbers of cytokine producing cells in patients with polymyositis and dermatomyositis
Hagiwara, E, Adams, E, Plotz, P, and Klinman, D, Clin Exp Rheum, 1/1/1996Update on therapies for refractory dermatomyositis and polymyositis
Villalba, L, and Adams, EM, Curr Op in Rheumatol, 1/1/1996- Join now to see all
Washington University/B-JH/SLCH ConsortiumFellowship, Rheumatology, 1988 - 1992
Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 1985 - 1988
Virginia Commonwealth University School of MedicineClass of 1985
Johns Hopkins UniversityB.Sc.E., Bioengineering, 1977 - 1981
MD State Medical License 1992 - 2026
PA State Medical License 1986 - 1988
